Project cooperation
Looking for Clinical trial of early diagnosis of kidney damage in patients
Argeron Nephrotest is an advanced in vitro diagnostic solution designed for the early detection of kidney damage.
- Research
- Execution
- Biotechnology
We focus on in vitro diagnostic kits and biomarker- based tests to enable the early diagnosis of age-related diseases. Our work encompasses solutions for cancer, kidney damage, Alzheimer's, and other neurodegenerative diseases, as well as understanding biological aging processes.
Additionally, we are working on formulations to slow down the rate of biological aging and extend healthy lifespan. Our products are certified with CE quality standards and manufactured in compliance with IVDR regulations. We successfully manage national and international patent processes.
Awards & Achievements
1st Prize in the Health Category at the 11th TET Project Market in Türkiye
Selected for Bayer G4A Turkey 2022 Health Category
Recognized as a Deep Technology Pioneer in the Health Field by Hello Tomorrow Global
Holder of 4 local and 22 international patents
Areas of Activities
Project cooperation
Looking for Clinical trial of early diagnosis of kidney damage in patients
Argeron Nephrotest is an advanced in vitro diagnostic solution designed for the early detection of kidney damage.
Expertise
Advanced Medical and Biotechnology Solutions Medical Research and Diagnostic Development
*Innovation in Medical Diagnostics and Therapeutics *Biotechnology and Healthcare Solutions
Partnership
Early detection of kidney injury
Is an advanced in vitro diagnostic solution designed for the early detection of kidney damage.
Partnership
Argeron Magnetic Auto Injector
Is based on a unique permanent magnetic propulsion system, designed to deliver controlled and consistent injections